Case Report

Hypertriglyceridemia induced recurrent pancreatitis case

Volume: 3 Number: Supplement 1 March 7, 2021
EN

Hypertriglyceridemia induced recurrent pancreatitis case

Abstract

ABSTRACT: Hypertriglyceridemia (HTG) is the third most common cause of acute pancreatitis (AP). It is caused by disorders in lipoprotein metabolism due to primary or secondary causes. Metabolic syndrome is also an important factor contributing to the development of HTG. The primary treatment goal in severe HTG is to restore triglyceride levels within normal ranges which can be achieved with lipid lowering drugs mainly fenofibrates, fluid replacement, intravenous insulin infusion and/ or plasmapheresis treatments. Strict diet restricted from fat and simple sugars, exercise and weight control also contribute to HTG control in long term follow up. In this report, a case of severe AP triggered by HTG with other metabolic syndrome components like type 2 diabetes mellitus and obesity is presented.

Keywords

Supporting Institution

Uludağ Üniversitesi

References

  1. Fortson MR, Freedman SN, Webster PD 3rd. Clinical assessment of hyperlipidemic pancreatitis. Am J Gastroenterol 1995; 90:2134.
  2. Tenner S, Baillie J, DeWitt J, Vege SS. American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol 2013;108:1400-15.
  3. Zhang W, et al. Hypertriglyceridemia aggravates ER stress and pathogenesis of acute pancreatitis. Hepatogastroenterology 2012;59:2318-26
  4. Gelrud A, Whitcomb DC. Hypertriglyceridemia-induced acute pancreatitis. Uptodate, 2021.

Details

Primary Language

English

Subjects

Clinical Sciences , ​Internal Diseases

Journal Section

Case Report

Publication Date

March 7, 2021

Submission Date

February 24, 2021

Acceptance Date

March 6, 2021

Published in Issue

Year 2021 Volume: 3 Number: Supplement 1

APA
Karaaslan, S., Aydemir, E., Ateş, C., Aydoğan Ünsal, Y., Ersoy, C., Öz Gül, Ö., Cander, S., & Ertürk, E. (2021). Hypertriglyceridemia induced recurrent pancreatitis case. Turkish Journal of Internal Medicine, 3(Supplement 1), 101-103. https://doi.org/10.46310/tjim.885774
AMA
1.Karaaslan S, Aydemir E, Ateş C, et al. Hypertriglyceridemia induced recurrent pancreatitis case. Turk J Int Med. 2021;3(Supplement 1):101-103. doi:10.46310/tjim.885774
Chicago
Karaaslan, Seda, Ensar Aydemir, Coşkun Ateş, et al. 2021. “Hypertriglyceridemia Induced Recurrent Pancreatitis Case”. Turkish Journal of Internal Medicine 3 (Supplement 1): 101-3. https://doi.org/10.46310/tjim.885774.
EndNote
Karaaslan S, Aydemir E, Ateş C, Aydoğan Ünsal Y, Ersoy C, Öz Gül Ö, Cander S, Ertürk E (March 1, 2021) Hypertriglyceridemia induced recurrent pancreatitis case. Turkish Journal of Internal Medicine 3 Supplement 1 101–103.
IEEE
[1]S. Karaaslan et al., “Hypertriglyceridemia induced recurrent pancreatitis case”, Turk J Int Med, vol. 3, no. Supplement 1, pp. 101–103, Mar. 2021, doi: 10.46310/tjim.885774.
ISNAD
Karaaslan, Seda - Aydemir, Ensar - Ateş, Coşkun - Aydoğan Ünsal, Yasemin - Ersoy, Canan - Öz Gül, Özen - Cander, Soner - Ertürk, Erdinç. “Hypertriglyceridemia Induced Recurrent Pancreatitis Case”. Turkish Journal of Internal Medicine 3/Supplement 1 (March 1, 2021): 101-103. https://doi.org/10.46310/tjim.885774.
JAMA
1.Karaaslan S, Aydemir E, Ateş C, Aydoğan Ünsal Y, Ersoy C, Öz Gül Ö, Cander S, Ertürk E. Hypertriglyceridemia induced recurrent pancreatitis case. Turk J Int Med. 2021;3:101–103.
MLA
Karaaslan, Seda, et al. “Hypertriglyceridemia Induced Recurrent Pancreatitis Case”. Turkish Journal of Internal Medicine, vol. 3, no. Supplement 1, Mar. 2021, pp. 101-3, doi:10.46310/tjim.885774.
Vancouver
1.Seda Karaaslan, Ensar Aydemir, Coşkun Ateş, Yasemin Aydoğan Ünsal, Canan Ersoy, Özen Öz Gül, Soner Cander, Erdinç Ertürk. Hypertriglyceridemia induced recurrent pancreatitis case. Turk J Int Med. 2021 Mar. 1;3(Supplement 1):101-3. doi:10.46310/tjim.885774

30994   34277 29166

 

Turkish Journal of Internal Medicine, hosted by DERGİPARK, is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

by-nc-nd.png